...
首页> 外文期刊>Journal of Medicinal Chemistry >Varenicline: An alpha 4 beta 2 nicotinic receptor partial agonist for smoking cessation
【24h】

Varenicline: An alpha 4 beta 2 nicotinic receptor partial agonist for smoking cessation

机译:瓦伦尼克碱:用于戒烟的α4β2烟碱样受体部分激动剂

获取原文
获取原文并翻译 | 示例
           

摘要

Herein we describe a novel series of compounds from which varenicline (1, 6,7,8,9-tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine) has been identified for smoking cessation. Neuronal nicotinic acetylcholine receptors (nAChRs) mediate the dependence-producing effects of nicotine. We have pursued α 4β 2 nicotinic receptor partial agonists to inhibit dopaminergic activation produced by smoking while simultaneously providing relief from the craving and withdrawal syndrome that accompanies cessation attempts. Varenicline displays high α 4β 2 nAChR affinity and the desired in vivo dopaminergic profile.
机译:在本文中,我们描述了一系列新的化合物,从中确定了瓦伦尼克林(1,6,7,8,9-四氢-6,10-甲醇-6H-吡嗪并[2,3-h] [3]苯并ze庚因)已被识别出可吸烟戒烟。神经元烟碱乙酰胆碱受体(nAChRs)介导尼古丁的依赖性产生作用。我们一直在追求α4β2烟碱样受体部分激动剂,以抑制吸烟产生的多巴胺能激活,同时缓解戒烟尝试带来的渴望和戒断综合症。瓦伦尼克碱显示出高的α4β2 nAChR亲和力和所需的体内多巴胺能谱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号